pyrroles has been researched along with natriuretic peptide, c-type in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, SQ; Lagranha, C; Puggina, E; Sellitti, DF | 1 |
| Casserly, B; Choudhary, G; Harrington, EO; Klinger, JR; Mazer, JM; Rounds, S; Vang, A | 1 |
| Gao, Y; Li, Y; Zeng, D | 1 |
3 other study(ies) available for pyrroles and natriuretic peptide, c-type
| Article | Year |
|---|---|
cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Topics: Animals; Bucladesine; Calcium; Carbazoles; Cell Line; Chelating Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Depression, Chemical; Dose-Response Relationship, Drug; Guanylate Cyclase; Immunohistochemistry; Indoles; Isoquinolines; Natriuretic Peptide, C-Type; Pyrroles; Rats; Receptors, Atrial Natriuretic Factor; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sulfonamides; Thyroid Gland; Thyrotropin; Time Factors | 2004 |
C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade.
Topics: Animals; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Indoles; Lung; Male; Natriuretic Agents; Natriuretic Peptide, C-Type; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor | 2011 |
Atorvastatin inhibits collar-induced intimal thickening of rat carotid artery: effect on C-type natriuretic peptide expression.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Carotid Artery Injuries; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Gene Expression Regulation; Heptanoic Acids; Male; Natriuretic Peptide, C-Type; Neointima; Pyrroles; Rats | 2012 |